Delirium in the NICU is an underrecognized phenomenon in infants who are often complex and critically ill. The current understanding of NICU delirium is developing and can be informed by adult and pediatric literature. The NICU population faces many potential risk factors for delirium, including young age, developmental delay, mechanical ventilation, severe illness, and surgery. There are no diagnostic tools specific to infants. The mainstay of delirium treatment is to treat the underlying cause, address modifiable risk factors, and supportive care. This review will summarize current knowledge and areas where more research is needed.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1038/s41372-023-01767-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Mobilization in Neurocritical Care: Challenges and Opportunities.
Curr Neurol Neurosci Rep
December 2024
Department of Neurology, Hospital of The University of Pennsylvania and Penn Presbyterian Medical Center, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
Purpose Of Review: Mobilization in the Neurological Intensive Care Unit (NICU) significantly improves outcomes and functional recovery while preventing immobility-related complications. The heterogeneity of neurologic conditions necessitates tailored, interdisciplinary mobilization strategies. This article reviews recent research on enhancing the feasibility and effectiveness of mobilization interventions in NICU settings.
View Article and Find Full Text PDFNeuroleptic Malignant Syndrome in a 10-Month-Old Ex-Preterm Infant with Delirium.
AJP Rep
July 2024
Division of Neonatology, Department of Pediatrics, Monroe Carell Jr. Children's Hospital at Vanderbilt, Nashville, Tennessee.
Article Synopsis
- - Atypical antipsychotics are increasingly used in the NICU to manage neonatal delirium, but caution is needed due to potential adverse effects like neuroleptic malignant syndrome (NMS).
- - NMS is a rare but serious reaction to antipsychotics, primarily seen in older children, but this case report highlights its occurrence in a 10-month-old infant treated with olanzapine.
- - Symptoms of NMS include hyperthermia and mental status changes, emphasizing the need for careful monitoring and management when prescribing antipsychotics to infants.
Current Evidence Regarding the Evaluation and Management of Neonatal Delirium.
Curr Psychiatry Rep
October 2024
Department of Psychiatry, Division of Child and Adolescent Psychiatry, University of Michigan Mott Children's Hospital, Ann Arbor, MI, USA.
Article Synopsis
- Newborns and infants in the NICU are at a high risk for developing delirium, but there's limited research focused specifically on this population.
- Current literature suggests that delirium may occur in these infants at rates similar to or even higher than in other healthcare settings.
- There is a significant lack of validated assessment tools for delirium in the NICU, highlighting the need for more targeted studies to establish effective management practices.
Implementing Screening for Neonatal Delirium in the Neonatal Intensive Care Unit: A Quality Improvement Initiative.
Pediatr Qual Saf
October 2024
Department of Pediatrics, University of California San Diego, La Jolla, Calif.
Article Synopsis
- Delirium is often overlooked in neonatal intensive care units (NICUs), but recognizing it is crucial for improving patient outcomes.
- A quality improvement initiative aimed to increase delirium screening from 0% to 85% in NICU patients by March 2022, utilizing interdisciplinary meetings and standardized tools.
- The initiative achieved an average screening compliance of 82% before discharge, demonstrating that structured efforts can enhance delirium recognition in the NICU and suggesting areas for future research on patient outcomes.
Gabapentin for Delirium in Infants in the Neonatal Intensive Care Unit.
J Pediatr Pharmacol Ther
October 2024
Department of Pharmacy: Clinical and Administrative Sciences (JLM, SBN, PNJ, AP), College of Pharmacy, University of Oklahoma Health Sciences Center, Oklahoma City, OK.
Objective: A protocol was developed for neonatal intensive care unit (NICU) delirium: Step 1, gabapentin for pain or melatonin for sleep; Step 2, add on other Step 1 agent; Step 3, antipsychotics. The purpose of this study was to describe the utility and dosing of gabapentin for NICU delirium.
Methods: Retrospective evaluation of NICU patients from January 1, 2021-December 31, 2022 who received >1 dose of gabapentin based on the delirium protocol.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!